4D Molecular Therapeutics CEO David Kirn disposes of $754,632 in common shares
FDMT•CEO David Kirn sold 58,333 shares on Oct. 5, 2026, at prices of $12.9215 and $13.6104 per share, reducing his direct holding to 709,153 shares.
FDMT•FDMT•FDMT•CEO David Kirn sold 58,333 shares on Oct. 5, 2026, at prices of $12.9215 and $13.6104 per share, reducing his direct holding to 709,153 shares.
4D Molecular Therapeutics President and CEO David Kirn sold 58,333 shares on Oct. 5, 2026, for a reported total value of $754,632. Sales were priced at $12.9215 and $13.6104 per share, and his direct holding fell to 709,153 shares.
